EXCLUSIVE LINE FOR PRACTITIONERS. TO OPEN A NEW ACCOUNT OR GAIN ACCESS TO THE PRACTITIONERS-ONLY PORTION OF OUR WEBSITE, PLEASE CALL: 877-776-8610. CANADIAN PRACTITIONERS PLEASE CALL 1-800-265-7245 EXT.721
Good Manufacturing Practices (GMPs) have been established by the Natural Products
...
Our expert team of highly qualified scientist and technicians work in tandem to develop new and
...BROWSE OUR SITE
References - Brain/Cognitive Protocol |
|
1. Bai DL, Tang XC, He XC. "Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease." Curr Med Chem. 2000 Mar;7(3):355-74.
2. Wang R, Yan H, Tang XC. "Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine." Acta Pharmacol Sin. 2006 Jan;27(1):1-26. 3. Veerendra Kumar MH, Gupta YK. "Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats." Clin Exp Pharmacol Physiol. 2003 May-Jun;30(5-6):336-42. 4. DeFeudis FV, Drieu K. "Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications." Curr Drug Targets. 2000 Jul;1(1):25-58. 5. Arwert LI, Deijen JB, Drent ML. "Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects." Nutr Neurosci. 2003 Oct;6(5):269-75. 6. Zangara A. "The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease." Pharmacol Biochem Behav. 2003 Jun;75(3):675-86. 7. Toffano, G. in Lecithin: Technological, Biological, and Therapeutic Agents, ed. I Hanin and G. B. Ansell. (New York: Plenum Press, 1987) 137-146. 8. Kennedy DO, Haskell CF, Mauri PL, Scholey. "Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine." Hum Psychopharmacol. 2007 Apr 25;22(4):199-210. 9. Rebouche CJ. "Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism." Ann N Y Acad Sci. 2004 Nov;1033:30-41. 10. White HL, Scates PW. "Acetyl-L-carnitine as a precursor of acetylcholine." Neurochem Res. 1990 Jun;15(6):597-601. 11. Pettegrew JW, Levine J, McClure RJ. "Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression." Mol Psychiatry. 2000 Nov;5(6):616-32. 12. Mondillo S, Faglia S, D'Aprile N, et al. "[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]" Clin Ter. 1995 Dec;146(12):769-74. Italian. 13. “Possible Interactions with: Carnitine (L-Carnitine)” on the University of Maryland Medical Center www.umm.edu/altmed/ConsSupplements/Interactions/CarnitineLCarnitinecs.html |